36 results
Page 2 of 2
424B3
wj4kt2spw4o57n2du
13 Aug 21
Prospectus supplement
5:25pm
8-K
EX-99.1
uxy h837qfdj8b
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
EX-99.1
moego1 oj
1 Jun 21
Business combination disclosure
4:30pm
S-4/A
EX-10.8
p4hxp0os4pw acynu
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
5n3imw3mqfvzi
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.7
ofkm6qtqu
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.12
q7i6my
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
EX-99.1
qvgfhlch0
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
EX-99.1
ke23p bbzpja
28 Apr 21
Business combination disclosure
5:11pm
S-4
EX-10.13
r3524c9dd8b9a
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.12
9cslkjs1
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.8
zw3q455 8ug8yc9j1d4
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.7
mqx58ulxg6u8i
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
425
EX-99.1
yjzs2v e5
15 Mar 21
Business combination disclosure
8:20am
8-K
EX-99.1
uua0cup
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am